Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CartiLife vs Microfracture for Knee Chondral Defects
NCT05051332Phase 3Unknown
- Sponsor
- Biosolution Co., Ltd.
- Start
- Mar 2020
- Primary completion
- Sep 2023
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 3 trial of CartiLife in Articular cartilage defect, sponsored by Biosolution Co., Ltd.. Status: unknown.
02
Drugs
CartiLife
03
Conditions
Articular cartilage defect
Beyond the preview
Go deeper on NCT05051332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05051332.